Session

IBD (Posters)

BIO-NAIVE CROHN'S DISEASE PATIENTS WITH LONG-STANDING DISEASE BENEFIT FROM USTEKINUMAB TREATMENT: REAL WORLD EXPERIENCE
BIO-NAIVE CROHN'S DISEASE PATIENTS WITH LONG-STANDING DISEASE BENEFIT FROM USTEKINUMAB TREATMENT: REAL WORLD EXPERIENCE

IBD (Posters)  et al.

SEROLOGICAL BIOMARKERS OF INTERSTITIAL MATRIX AND BASEMENT MEMBRANE REMODELLING CORRELATES THE MODIFIED MAYO ENDOSCOPIC SCORE (MMES) FOR ULCERATIVE COLITIS
SEROLOGICAL BIOMARKERS OF INTERSTITIAL MATRIX AND BASEMENT MEMBRANE REMODELLING CORRELATES THE MODIFIED MAYO ENDOSCOPIC SCORE (MMES) FOR ULCERATIVE COLITIS

IBD (Posters)  et al.

EMERGING ROLE OF IL-33/ST2 AND GUT MICROBIOTA AXIS IN PREDICTING MUCOSAL AND HISTOLOGICAL RESPONSE TO ANTI-TNF THERAPY IN ULCERATIVE COLITIS
EMERGING ROLE OF IL-33/ST2 AND GUT MICROBIOTA AXIS IN PREDICTING MUCOSAL AND HISTOLOGICAL RESPONSE TO ANTI-TNF THERAPY IN ULCERATIVE COLITIS

IBD (Posters)  et al.

CHARACTERIZATION OF MUCOSAL CYTOKINE PROFILE IN ULCERATIVE COLITIS PATIENTS UNDER CONVENTIONAL AND ANTI-TNF-A TREATMENT
CHARACTERIZATION OF MUCOSAL CYTOKINE PROFILE IN ULCERATIVE COLITIS PATIENTS UNDER CONVENTIONAL AND ANTI-TNF-A TREATMENT

IBD (Posters)  et al.

HIGHER VS STANDARD ADALIMUMAB INDUCTION AND MAINTENANCE TREATMENT IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS: INTEGRATED RESULTS FROM THE PHASE 3 SERENE-UC STUDY
HIGHER VS STANDARD ADALIMUMAB INDUCTION AND MAINTENANCE TREATMENT IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS: INTEGRATED RESULTS FROM THE PHASE 3 SERENE-UC STUDY

IBD (Posters)  et al.

DEEP ENDOSCOPIC ULCERATIONS ARE NOT ASSOCIATED WITH THE NEED FOR SURGERY OR COMPLICATED BEHAVIOR: A POPULATION-BASED STUDY
DEEP ENDOSCOPIC ULCERATIONS ARE NOT ASSOCIATED WITH THE NEED FOR SURGERY OR COMPLICATED BEHAVIOR: A POPULATION-BASED STUDY

IBD (Posters)  et al.

RISK OF PREVALENT ASTHMA AMONG CHILDREN AFFECTED BY INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED BIRTH COHORT STUDY
RISK OF PREVALENT ASTHMA AMONG CHILDREN AFFECTED BY INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED BIRTH COHORT STUDY

IBD (Posters)  et al.

THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN BIO-NAïVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE - AN INTERIM ANALYSIS FROM A DANISH NATIONAL COHORT STUDY
THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN BIO-NAïVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE - AN INTERIM ANALYSIS FROM A DANISH NATIONAL COHORT STUDY

IBD (Posters)  et al.

IBD-RELATED MALIGNANCIES OBSERVED IN 2015-2019 - 4 YEARS' RESULTS FROM THE PROSPECTIVE, NATIONWIDE HUNGARIAN REGISTRY
IBD-RELATED MALIGNANCIES OBSERVED IN 2015-2019 - 4 YEARS' RESULTS FROM THE PROSPECTIVE, NATIONWIDE HUNGARIAN REGISTRY

IBD (Posters)  et al.

EFFICACY AND SAFETY OF RE-INDUCTION WITH INTRAVENOUS USTEKINUMAB IN PATIENTS WITH CROHN´S DISEASE AND LOSS OF RESPONSE TO THAT DRUG
EFFICACY AND SAFETY OF RE-INDUCTION WITH INTRAVENOUS USTEKINUMAB IN PATIENTS WITH CROHN´S DISEASE AND LOSS OF RESPONSE TO THAT DRUG

IBD (Posters)  et al.

MEASUREMENT OF ULCERATED AND AFFECTED SURFACE OF THE COLON MAY PROVIDE MORE INSIGHT INTO RESPONSE COMPARED TO ENDOSCOPIC MAYO SCORE - A POST HOC ANALYSIS
MEASUREMENT OF ULCERATED AND AFFECTED SURFACE OF THE COLON MAY PROVIDE MORE INSIGHT INTO RESPONSE COMPARED TO ENDOSCOPIC MAYO SCORE - A POST HOC ANALYSIS

IBD (Posters)  et al.

VEDOLIZUMAB CLINICAL DECISION SUPPORT TOOL PREDICTS EFFICACY OF VEDOLIZUMAB BUT NOT USTEKINUMAB IN REFRACTORY CROHN'S DISEASE
VEDOLIZUMAB CLINICAL DECISION SUPPORT TOOL PREDICTS EFFICACY OF VEDOLIZUMAB BUT NOT USTEKINUMAB IN REFRACTORY CROHN'S DISEASE

IBD (Posters)  et al.

THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES - A DOUBLE-CENTER DANISH EXPERIENCE
THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES - A DOUBLE-CENTER DANISH EXPERIENCE

IBD (Posters)  et al.

EFFICACY OF USTEKINUMAB FOR ACTIVE PERIANAL FISTULIZING CROHN'S DISEASE: A DOUBLE CENTER COHORT STUDY AND A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CURRENT LITERATURE
EFFICACY OF USTEKINUMAB FOR ACTIVE PERIANAL FISTULIZING CROHN'S DISEASE: A DOUBLE CENTER COHORT STUDY AND A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CURRENT LITERATURE

IBD (Posters)  et al.

THE DIAGNOSTIC PERFORMANCE OF A TRAINED PHYSICIAN VS. A PEDIATRIC RADIOLOGIST IN PERFORMING AN INTESTINAL ULTRASOUND IN CHILDREN WITH IBD
THE DIAGNOSTIC PERFORMANCE OF A TRAINED PHYSICIAN VS. A PEDIATRIC RADIOLOGIST IN PERFORMING AN INTESTINAL ULTRASOUND IN CHILDREN WITH IBD

IBD (Posters)  et al.

SYSTEMATIC REVIEW AND META-ANALYSIS: THE IMPACT OF CONCOMITANT IMMUNE-MEDIATED DISEASES ON THE DISEASE LOCALIZATION AND BEHAVIOUR IN PATIENTS WITH CROHN'S DISEASE
SYSTEMATIC REVIEW AND META-ANALYSIS: THE IMPACT OF CONCOMITANT IMMUNE-MEDIATED DISEASES ON THE DISEASE LOCALIZATION AND BEHAVIOUR IN PATIENTS WITH CROHN'S DISEASE

IBD (Posters)  et al.

PROGNOSIS OF CROHN'S DISEASE PATIENTS RECEIVING ANTI-TNF THERAPY ACCORDING TO ENDOSCOPIC HEALING OR RADIOLOGIC HEALING
PROGNOSIS OF CROHN'S DISEASE PATIENTS RECEIVING ANTI-TNF THERAPY ACCORDING TO ENDOSCOPIC HEALING OR RADIOLOGIC HEALING

IBD (Posters)  et al.

REGULATORS OF THE GUANYLATE CYCLASE PATHWAY ARE POTENTIAL NOVEL MARKERS OF MUCOSAL HEALING IN IBD
REGULATORS OF THE GUANYLATE CYCLASE PATHWAY ARE POTENTIAL NOVEL MARKERS OF MUCOSAL HEALING IN IBD

IBD (Posters)  et al.

THE POTENTIAL ROLE OF PROCALCITONIN AS A NOVEL SERUM INFLAMMATORY BIOMARKER IN ULCERATIVE COLITIS (UC) AND CROHN´S DISEASE (CD)
THE POTENTIAL ROLE OF PROCALCITONIN AS A NOVEL SERUM INFLAMMATORY BIOMARKER IN ULCERATIVE COLITIS (UC) AND CROHN´S DISEASE (CD)

IBD (Posters)  et al.

PROACTIVE INFLIXIMAB DRUG MONITORING INDUCES FECAL BIOMARKER REMISSION IN INFLAMMATORY BOWEL DISEASE
PROACTIVE INFLIXIMAB DRUG MONITORING INDUCES FECAL BIOMARKER REMISSION IN INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

Item 141 - 160 / 279
1 2 3 4 5 6 7
8
9 10 11 12 13 14